Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant RT +/- Cisplatin/Taxol in Endometrial Cancer
NCT00006027Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Aug 2000
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cisplatin, paclitaxel in endometrial cancer (EC), sponsored by NRG Oncology. Started Aug 2000; status: completed.
02
Drugs
cisplatinpaclitaxel
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00006027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006027.